【摘要】 目的 :评价肝素抑制后发性白内障的远期疗效。方法 :对 4 7例 (肝素组 2 4例、对照组 2 3例 )白内障囊外摘除及后房型人工晶状体植入术后的病例随访观察 2 4至 36个月、平均 2 6个月。结果 :肝素组的后囊混浊发生率为 1 7% ,明显低于对照组的 56 5% (P <0 0 1 ) ;肝素组的矫正视力为 0 65±0 2 2 ,明显高于对照组的矫正视力 0 33± 0 2 4 (P <0 0 5)。结论 :肝素抑制后发性白内障的远期效果是肯定的。更多还原

【Abstract】 Objective:To evaluate long efficacy of heparin against after cataract.Methods:47 cases of cataract extraction with intraocular lens implantation were followed by 24-36 months,average 26 months.47 cases include 23 cases in the control group,and 24 cases in the heparin solution (25U/ml)group in the operation.Results:The incidence of the posterior capsular opacification is 17% in drug group.It was prominent lower than 56 5% in the control group.The corrected visual acuity in the drug group was 0 65±0 22,higher than 0 33±0 24 in the control group.Conclusion:The long efficacy of heparin against after cataract is affirmative.更多还原